DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations

M.D. Joshi; W.W.J. Unger; A.J. van Beelen; S.C.M. Bruijns; M. Litjens; L. van Bloois; H. Kalay; Y. van Kooyk; G. Storm

doi:10.1016/j.ijpharm.2011.02.055

DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations

M.D. Joshi, W.W.J. Unger, A.J. van Beelen, S.C.M. Bruijns, M. Litjens, L. van Bloois, H. Kalay, Y. van Kooyk, G. Storm

Research output: Contribution to journal › Article › Academic › peer-review

32 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	426-432
Journal	International journal of pharmaceutics
Volume	416
Issue number	2
DOIs	https://doi.org/10.1016/j.ijpharm.2011.02.055
Publication status	Published - 2011

Access to Document

10.1016/j.ijpharm.2011.02.055

Cite this

@article{5f122b7822eb4f72894b0dc718b9553d,

title = "DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations",

author = "M.D. Joshi and W.W.J. Unger and {van Beelen}, A.J. and S.C.M. Bruijns and M. Litjens and {van Bloois}, L. and H. Kalay and {van Kooyk}, Y. and G. Storm",

year = "2011",

doi = "10.1016/j.ijpharm.2011.02.055",

language = "Undefined/Unknown",

volume = "416",

pages = "426--432",

journal = "International journal of pharmaceutics",

issn = "0378-5173",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations

AU - Joshi, M.D.

AU - Unger, W.W.J.

AU - van Beelen, A.J.

AU - Bruijns, S.C.M.

AU - Litjens, M.

AU - van Bloois, L.

AU - Kalay, H.

AU - van Kooyk, Y.

AU - Storm, G.

PY - 2011

Y1 - 2011

U2 - 10.1016/j.ijpharm.2011.02.055

DO - 10.1016/j.ijpharm.2011.02.055

M3 - Article

C2 - 21371544

SN - 0378-5173

VL - 416

SP - 426

EP - 432

JO - International journal of pharmaceutics

JF - International journal of pharmaceutics

IS - 2

ER -